Abstract
Differential Target MultiplexedTM (DTMTM) spinal cord stimulation (SCS) paradigm has been studied via a multicenter randomized clinical trial. Using the Medtronic CareGuideProTM (CGP) digital health platform, we present the real-world evidence (RWE) of DTMTM SCS Trial journey and clinical outcomes.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Paper Title
Journal
Date
